Catalyst Wire Dossier Catalyst Wire Dossier

Optical Coherence Tomography Drug Eluting Stent

drug-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Optical Coherence Tomography Drug Eluting Stent, covering 2017-03-01 to 2017-03-01. Get the full timeline:

Most recent: Clinical Trial Update: The Optical Coherence Tomography Drug Eluting Stent Investigation [NA]

See pricing